Search For "serum institute of india"
'Secret behind high speed of Russia's COVID-19 vaccine creation was the co
Updated : 5 years, 11 months ago IST
Moscow [Russia], August 11 (ANI): After the first coronavirus vaccine in the world was registered in Russia, Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev said, in his opinion piece for Sputnik, that the secret behind the high speed of Russia's COVID-19 vaccine creation was the c
Read More
SII enters into new partnership to accelerate manufacture, delivery of COV
Updated : 5 years, 11 months ago IST
New Delhi [India], Aug 7 (ANI): The Serum Institute of India (SII) has entered into a new landmark partnership with Gavi, the Vaccine Alliance and the Bill and Melinda Gates Foundation, to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for India and l
Read More
DCGI gives nod to Serum Institute to hold Phase II, III COVID vaccine tria
Updated : 5 years, 11 months ago IST
New Delhi [India], Aug 3 (ANI): The Drugs Controller General of India (DCGI) gave approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India, said the Ministry of Health and Family Welfare on
Read More
DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3 clinical trials in
Updated : 5 years, 11 months ago IST
New Delhi, [India], Aug 3 (ANI) India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine, a senior government official said.
Read More
Drug regulator gets committee approval for nod to clinical trials by Serum
Updated : 5 years, 11 months ago IST
New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-1
Read More
Drug Regulator asks Serum Institute to furnish revised protocol for COVID-
Updated : 5 years, 11 months ago IST
New Delhi [India], July 29 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has advised the Serum Institute of India (SII) to submit a revised protocol to perform the clinical trials in India for potential COVID-19 vaccine.
Read More
Domestic pharma giant SII applies to DCGI for phase 2/3 clinical trial of
Updated : 5 years, 11 months ago IST
New Delhi [India], July 25 (ANI): In a development related to the COVID-19 vaccine, the Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) for conducting the Phase 2/3 human clinical trials for a potential coronavirus vaccine.
Read More
DCGI gives market approval for Pneumococcal Polysaccharide Conjugate Vacci
Updated : 6 years ago IST
New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has given approval to the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine.
Read More
Covid-19 fallout: SII signs deal with Astra Zeneca to manufacture vaccines
Updated : 6 years, 1 month ago IST
New Delhi [India], June 13 (ANI): Adar Poonawalla, CEO and Owner, Serum Institute of India (SII) on Saturday announced that his firm has signed a deal with Astra Zeneca to supply one billion doses of vaccine for low and middle-income countries before the end of 2020 to combat coronavirus.
Read More
New pneumococcal vaccine from Serum Institute of India achieves WHO prequa
Updated : 6 years, 6 months ago IST
Seattle (USA)/Pune (Maharashtra) [India] Dec 23 (ANI/NewsVoir): PNEUMOSIL®, a vaccine against a leading cause of deadly childhood pneumonia - the pneumococcus bacterium - has achieved prequalification by the World Health Organization (WHO).
Read More
Svasti Microfinance raises Rs. 34 crores from Nordic Microfinance Initiati
Updated : 7 years, 5 months ago IST
New Delhi [India], Feb 12 (ANI): Svasti Microfinance Private Limited (Svasti) has raised a total of Rs. 34 Crores capital from Nordic Microfinance Initiative (NMI), Serum Institute of India CEO Adar Poonawalla, and other investors.
Read More
Dr. Cyrus Poonawalla congratulated for life-long commitment to boosting va
Updated : 7 years, 7 months ago IST
New Delhi [India], Dec 17 (ANI-BusinessWireIndia): Dr. Cyrus Poonawalla, Founder of Serum Institute of India (SII) and Chairman of Poonawalla Group, has been given the first ever Vaccine Hero award by Gavi, the Vaccine Alliance.
Read More